Search research articles
Contact Us
Filters
Showing results (101-110 of 133) with videos related to
Page
of 14
Sort By:
Archives of Internal Medicine
|
October 1, 1988
Relationship of aluminum to neurocognitive dysfunction in chronic dialysis patients
S M Sprague, H L Corwin, C M Tanner, et al.
Neurology
|
September 1, 1993
Double-blind, placebo-controlled, crossover study of duodenal infusion of levodopa/carbidopa in Parkinson's disease patients with 'on-off' fluctuations
M C Kurth, J W Tetrud, C M Tanner, et al.
Neurology
|
July 1, 1988
Controlled-release carbidopa/levodopa (CR4-Sinemet) in Parkinson's disease patients with and without motor fluctuations
C G Goetz, C M Tanner, K M Shannon, et al.
Spine
|
June 1, 2000
The rates of false-positive lumbar discography in select patients without low back symptoms
E J Carragee, C M Tanner, S Khurana, et al.
Neuroscience Letters
|
November 22, 1988
An antibody in the CSF of Parkinson's disease patients disappears following adrenal medulla transplantation
A McRae-Degueurce, H L Klawans, R D Penn, et al.
Neurology
|
July 1, 1996
CYP2D6 allelic frequencies in young-onset Parkinson's disease
M S Sandy, M Armstrong, C M Tanner, et al.
Neurosurgery
|
June 1, 1988
The adrenal medullary transplant operation for Parkinson's disease: clinical observations in five patients
R D Penn, C G Goetz, C M Tanner, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 1, 1990
L-acetyl-carnitine in Huntington's disease: double-blind placebo controlled crossover study of drug effects on movement disorder and dementia
C G Goety, C M Tanner, J A Cohen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 22, 2001
An impairment in sniffing contributes to the olfactory impairment in Parkinson's disease
N Sobel, M E Thomason, I Stappen, et al.
Neurology
|
November 9, 2005
Excessive daytime sleepiness and subsequent development of Parkinson disease
R D Abbott, G W Ross, L R White, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 133) with videos related to
Sort By:
Page
of 14
Archives of Internal Medicine
|
October 1, 1988
Relationship of aluminum to neurocognitive dysfunction in chronic dialysis patients
S M Sprague, H L Corwin, C M Tanner, et al.
Neurology
|
September 1, 1993
Double-blind, placebo-controlled, crossover study of duodenal infusion of levodopa/carbidopa in Parkinson's disease patients with 'on-off' fluctuations
M C Kurth, J W Tetrud, C M Tanner, et al.
Neurology
|
July 1, 1988
Controlled-release carbidopa/levodopa (CR4-Sinemet) in Parkinson's disease patients with and without motor fluctuations
C G Goetz, C M Tanner, K M Shannon, et al.
Spine
|
June 1, 2000
The rates of false-positive lumbar discography in select patients without low back symptoms
E J Carragee, C M Tanner, S Khurana, et al.
Neuroscience Letters
|
November 22, 1988
An antibody in the CSF of Parkinson's disease patients disappears following adrenal medulla transplantation
A McRae-Degueurce, H L Klawans, R D Penn, et al.
Neurology
|
July 1, 1996
CYP2D6 allelic frequencies in young-onset Parkinson's disease
M S Sandy, M Armstrong, C M Tanner, et al.
Neurosurgery
|
June 1, 1988
The adrenal medullary transplant operation for Parkinson's disease: clinical observations in five patients
R D Penn, C G Goetz, C M Tanner, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 1, 1990
L-acetyl-carnitine in Huntington's disease: double-blind placebo controlled crossover study of drug effects on movement disorder and dementia
C G Goety, C M Tanner, J A Cohen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 22, 2001
An impairment in sniffing contributes to the olfactory impairment in Parkinson's disease
N Sobel, M E Thomason, I Stappen, et al.
Neurology
|
November 9, 2005
Excessive daytime sleepiness and subsequent development of Parkinson disease
R D Abbott, G W Ross, L R White, et al.
Page
of 14